Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915967 · ClinicalTrials.gov registry record · NA
Prevention of Neurosurgical Wound Infections
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT00915967 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 214 participants.
The verdict
NCT00915967, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.
Interventions
- DRUG Vancomycin
- DRUG Placebo (Saline Solution)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2009-05-13 |
| Est. Completion | 2014-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00915967
The ClinicalTrials.gov registry entry for NCT00915967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.
NCT00915967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00915967 about?
NCT00915967 is a clinical study titled "Prevention of Neurosurgical Wound Infections". The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.
What is the current status of trial NCT00915967?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2009-05-13. Estimated completion is 2014-12-19.
What interventions are being tested in trial NCT00915967?
The interventions under investigation include: Vancomycin (DRUG), Placebo (Saline Solution) (DRUG).
Who is sponsoring clinical trial NCT00915967?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.